122 related articles for article (PubMed ID: 1408307)
1. Differential antinociceptive effects of morphine and methylmorphine in the formalin test.
Oluyomi AO; Hart SL; Smith TW
Pain; 1992 Jun; 49(3):415-418. PubMed ID: 1408307
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of mice bred for stress-induced analgesia to morphine and ACEA-1011 in the formalin test.
Lutfy K; Sadowski B; Marek P; Kwon IS; Keana JF; Weber E
Pharmacol Biochem Behav; 1996 Jun; 54(2):495-500. PubMed ID: 8743614
[TBL] [Abstract][Full Text] [Related]
3. Naloxone blocks the beneficial effects of aqueous extract of Murraya koenigii (L.) Spreng leaves in models of pain.
Gupta R; Gupta LK; Bhattacharya SK
Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1748-51. PubMed ID: 23852898
[TBL] [Abstract][Full Text] [Related]
4. The peripheral antinociceptive effect of morphine in a rat model of facial pain.
Eisenberg E; Vos BP; Strassman AM
Neuroscience; 1996 May; 72(2):519-25. PubMed ID: 8737420
[TBL] [Abstract][Full Text] [Related]
5. Antinociceptive effects of (O-methyl)-N-benzoyl tyramine (riparin I) from Aniba riparia (Nees) Mez (Lauraceae) in mice.
Araújo FL; Melo CT; Rocha NF; Moura BA; Leite CP; Amaral JF; Barbosa-Filho JM; Gutierrez SJ; Vasconcelos SM; Viana GS; de Sousa FC
Naunyn Schmiedebergs Arch Pharmacol; 2009 Oct; 380(4):337-44. PubMed ID: 19557396
[TBL] [Abstract][Full Text] [Related]
6. Antinociceptive models displaying peripheral opioid activity.
Smith TW; Follenfant RL; Ferreira SH
Int J Tissue React; 1985; 7(1):61-7. PubMed ID: 3891654
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats.
Shannon HE; Lutz EA
Neuropharmacology; 2002 Feb; 42(2):253-61. PubMed ID: 11804622
[TBL] [Abstract][Full Text] [Related]
8. The Peripheral Versus Central Antinociception of a Novel Opioid Agonist: Acute Inflammatory Pain in Rats.
Balogh M; Zádori ZS; Lázár B; Karádi D; László S; Mousa SA; Hosztafi S; Zádor F; Riba P; Schäfer M; Fürst S; Al-Khrasani M
Neurochem Res; 2018 Jun; 43(6):1250-1257. PubMed ID: 29725918
[TBL] [Abstract][Full Text] [Related]
9. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Wettstein JG; Grouhel A
Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
[TBL] [Abstract][Full Text] [Related]
10. Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice.
Cendán CM; Pujalte JM; Portillo-Salido E; Baeyens JM
Psychopharmacology (Berl); 2005 Nov; 182(4):485-93. PubMed ID: 16075285
[TBL] [Abstract][Full Text] [Related]
11. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat.
Fürst S; Riba P; Friedmann T; Tímar J; Al-Khrasani M; Obara I; Makuch W; Spetea M; Schütz J; Przewlocki R; Przewlocka B; Schmidhammer H
J Pharmacol Exp Ther; 2005 Feb; 312(2):609-18. PubMed ID: 15383636
[TBL] [Abstract][Full Text] [Related]
12. 14-O-Methylmorphine: A Novel Selective Mu-Opioid Receptor Agonist with High Efficacy and Affinity.
Zádor F; Balogh M; Váradi A; Zádori ZS; Király K; Szűcs E; Varga B; Lázár B; Hosztafi S; Riba P; Benyhe S; Fürst S; Al-Khrasani M
Eur J Pharmacol; 2017 Nov; 814():264-273. PubMed ID: 28864212
[TBL] [Abstract][Full Text] [Related]
13. Role of kappa- and delta-opioid receptors in the antinociceptive effect of oxytocin in formalin-induced pain response in mice.
Reeta Kh; Mediratta PK; Rathi N; Jain H; Chugh C; Sharma KK
Regul Pept; 2006 Jul; 135(1-2):85-90. PubMed ID: 16712978
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive activity of a synthetic curcuminoid analogue, 2,6-bis-(4-hydroxy-3-methoxybenzylidene)cyclohexanone, on nociception-induced models in mice.
Ming-Tatt L; Khalivulla SI; Akhtar MN; Mohamad AS; Perimal EK; Khalid MH; Akira A; Lajis N; Israf DA; Sulaiman MR
Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):275-82. PubMed ID: 21967232
[TBL] [Abstract][Full Text] [Related]
15. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
16. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of montelukast in the animal models of pain.
Ghorbanzadeh B; Mansouri MT; Sahraei H; Alboghobeish S
Eur J Pharmacol; 2016 May; 779():38-45. PubMed ID: 26948314
[TBL] [Abstract][Full Text] [Related]
17. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Mansouri MT; Naghizadeh B; Ghorbanzadeh B
Pharmacol Biochem Behav; 2014 May; 120():43-9. PubMed ID: 24561064
[TBL] [Abstract][Full Text] [Related]
18. Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray.
Manning BH; Franklin KB
Behav Brain Res; 1998 Apr; 92(1):97-102. PubMed ID: 9588689
[TBL] [Abstract][Full Text] [Related]
19. Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test.
Azhdari-Zarmehri H; Esmaeili MH; Sofiabadi M; Haghdoost-Yazdi H
Pharmacol Biochem Behav; 2013 Nov; 112():64-70. PubMed ID: 24125787
[TBL] [Abstract][Full Text] [Related]
20. Supraspinal NMDA and non-NMDA receptors are differentially involved in the production of antinociception by morphine and beta-endorphin administered intracerebroventricularly in the formalin pain model.
Chung KM; Song DK; Huh SO; Kim YH; Choi MR; Suh HW
Neuropeptides; 2000; 34(3-4):158-66. PubMed ID: 11021975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
